A multi‐cohort study of longitudinal and cross‐sectional Alzheimer's disease biomarkers in cognitively unimpaired older adults

We investigated neuroimaging and cognitive biomarkers in 3036 cognitively unimpaired (CU) participants. Medial temporal lobe (MTL) tau and longitudinal MTL atrophy best separate amyloid beta positive (A+) CU from amyloid beta negative (A-) CU. A- tau positive (T+) CU had a significantly faster neurodegeneration rate compared to A-T- CU. MTL tau correlated with structural magnetic resonance imaging (MRI) and cognition regardless of amyloid beta status. Combined baseline MTL tau, MRI, and cognition best predict Alzheimer's disease progression.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-01-27
DOI
https://doi.org/10.1002/alz.14492
Citations
9
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
13.24

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A multi‐cohort study of longitudinal and cross‐sectional Alzheimer's disease biomarkers in cognitively unimpaired older adults

Amanda E Denning, Shokufeh Sadaghiani, Long Xie, Ujashi Shah et al.
9 citations
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
13.24
article

A multi‐cohort study of longitudinal and cross‐sectional Alzheimer's disease biomarkers in cognitively unimpaired older adults

Amanda E Denning, Shokufeh Sadaghiani, Long Xie, Ujashi Shah, Ranjit Ittyerah, S. J. Wolk, Stanislau Hrybouski, Pulkit Khandelwal, Eli Gibson, Niyousha Sadeghpour, Lasya P Sreepada, Michael DiCalogero, Mengjin Dong, Robin de Florès, Sandhitsu R. Das, Laura E.M. Wisse, Paul A. Yushkevich, Jesse Cohen, Xueying Lyu, Christopher Brown, Sadhana Ravikumar, Yue Li, Emily McGrew, Ademola Ilesanmi
article en
9 citations

Abstract

We investigated neuroimaging and cognitive biomarkers in 3036 cognitively unimpaired (CU) participants. Medial temporal lobe (MTL) tau and longitudinal MTL atrophy best separate amyloid beta positive (A+) CU from amyloid beta negative (A-) CU. A- tau positive (T+) CU had a significantly faster neurodegeneration rate compared to A-T- CU. MTL tau correlated with structural magnetic resonance imaging (MRI) and cognition regardless of amyloid beta status. Combined baseline MTL tau, MRI, and cognition best predict Alzheimer's disease progression.

Alzheimer s & DementiaVol. 21(2)
Inserm (FR), Lund University (SE), Penn Center for AIDS Research (US), Siemens (United States) (US), Siemens Healthcare (United States) (US), University of Pennsylvania (US), Université de Caen Normandie (FR)
U.S. Department of Defense, Alzheimer's Association, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Brigham and Women's Hospital, Massachusetts General Hospital, Biogen, University of Southern California, BrightFocus Foundation, Meso Scale Diagnostics, BioClinica, Novartis Pharmaceuticals Corporation, Northern California Institute for Research and Education, Fred A. And Barbara M. Erb Family Foundation, GHR Foundation, Lewy Body Dementia Association, Eisai, Servier, H. Lundbeck A/S, IXICO, Fondation Philippe Chatrier, National Institutes of Health, Genentech, Canadian Institutes of Health Research
Good health and well-being
Openalex Percentile: Top 1%
Dementia and Cognitive Impairment Research
13.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.